chr2-128113210-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_020120.4(UGGT1):āc.648A>Gā(p.Ser216=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000824 in 1,612,794 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0044 ( 2 hom., cov: 30)
Exomes š: 0.00045 ( 5 hom. )
Consequence
UGGT1
NM_020120.4 synonymous
NM_020120.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.101
Genes affected
UGGT1 (HGNC:15663): (UDP-glucose glycoprotein glucosyltransferase 1) UDP-glucose:glycoprotein glucosyltransferase (UGT) is a soluble protein of the endoplasmic reticulum (ER) that selectively reglucosylates unfolded glycoproteins, thus providing quality control for protein transport out of the ER.[supplied by OMIM, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 2-128113210-A-G is Benign according to our data. Variant chr2-128113210-A-G is described in ClinVar as [Benign]. Clinvar id is 778001.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.101 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UGGT1 | NM_020120.4 | c.648A>G | p.Ser216= | synonymous_variant | 6/41 | ENST00000259253.11 | NP_064505.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UGGT1 | ENST00000259253.11 | c.648A>G | p.Ser216= | synonymous_variant | 6/41 | 1 | NM_020120.4 | ENSP00000259253 | P1 | |
UGGT1 | ENST00000376723.7 | c.*688A>G | 3_prime_UTR_variant, NMD_transcript_variant | 6/41 | 1 | ENSP00000365913 | ||||
UGGT1 | ENST00000438277.5 | c.*236A>G | 3_prime_UTR_variant, NMD_transcript_variant | 4/26 | 1 | ENSP00000392701 |
Frequencies
GnomAD3 genomes AF: 0.00439 AC: 669AN: 152248Hom.: 2 Cov.: 30
GnomAD3 genomes
AF:
AC:
669
AN:
152248
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00107 AC: 268AN: 249738Hom.: 2 AF XY: 0.000733 AC XY: 99AN XY: 135054
GnomAD3 exomes
AF:
AC:
268
AN:
249738
Hom.:
AF XY:
AC XY:
99
AN XY:
135054
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000449 AC: 656AN: 1460428Hom.: 5 Cov.: 29 AF XY: 0.000381 AC XY: 277AN XY: 726558
GnomAD4 exome
AF:
AC:
656
AN:
1460428
Hom.:
Cov.:
29
AF XY:
AC XY:
277
AN XY:
726558
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00442 AC: 673AN: 152366Hom.: 2 Cov.: 30 AF XY: 0.00409 AC XY: 305AN XY: 74510
GnomAD4 genome
AF:
AC:
673
AN:
152366
Hom.:
Cov.:
30
AF XY:
AC XY:
305
AN XY:
74510
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at